These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16812)

  • 1. Ditazole and platelets. I. Effect of ditazole on human platelet function in vitro.
    De Gaetano G; Tonolli MC; Bertoni MP; Roncaglioni MC
    Haemostasis; 1977; 6(2):127-36. PubMed ID: 16812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ditazole and platelets. II. Effect of ditazole on in vivo platelet aggregation and bleeding time in rats.
    De Gaetano G; Cavenaghi AE; Stella L
    Haemostasis; 1977; 6(3):190-6. PubMed ID: 18382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro investigation on the antiaggregating activity of ditazole.
    Prisco D; Favilla S; Fortini A; Gensini GF
    Int J Clin Pharmacol Res; 1984; 4(5):341-7. PubMed ID: 6151552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of clot retraction from platelet granule fusion and degranulation: an ultrastructural study of Reptilase-human platelet-rich plasma clots.
    De Clerck F; Borgers M; de Gaetano G; Vermylen J
    Br J Haematol; 1975 Feb; 29(2):341-8. PubMed ID: 1191554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity ratio between antiprostacyclin and antiaggregating effects of acetylsalicylic acid, indometacin and ditazole.
    Caprino L; Togna G; Antonetti F; Borrelli F
    Arzneimittelforschung; 1980; 30(3):406-9. PubMed ID: 6104493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a single Ditazole dose on platelet aggregation and prostaglandin formation.
    Prisco D; Bartoletti A; Lombardi A
    Int J Clin Pharmacol Res; 1984; 4(2):129-36. PubMed ID: 6147319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated reptilase clot retraction of dog platelet-rich plasma: differences with human platelet-rich plasma.
    De Clerck F; Verheyen A; Vermylen J; Reneman R
    Scand J Haematol; 1975 Dec; 15(5):347-58. PubMed ID: 1202624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat.
    Clowes AW; Karnovsky MJ
    Lab Invest; 1977 Apr; 36(4):452-64. PubMed ID: 846193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ditazole and platelets III. Effect of ditazole on tumor-cell induced thrombocytopenia and on bleeding time in mice.
    Mussoni L; Poggi A; Donati MB; de Gaetano G
    Haemostasis; 1977; 6(4):260-5. PubMed ID: 21124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interactions between ditazole and anticoagulant drugs.
    Caprino L; Falchetti R; Borrelli F
    Arzneimittelforschung; 1975; 25(12):1920-3. PubMed ID: 56180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of mithramycin on some platelet functions in vitro.
    Kubisz P; Klener P; Cronberg S
    Acta Haematol; 1980; 63(2):101-6. PubMed ID: 6445152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents.
    Kirkpatrick JP; McIntire LV; Moake JL; Cimo PL
    Thromb Haemost; 1980 Feb; 42(5):1483-9. PubMed ID: 6892735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of teniposide on platelet functions in vitro.
    Kubisz P; Seghier F; Dobrotorá M; Stasko J; Cronberg S
    Thromb Res; 1995 Jan; 77(2):145-8. PubMed ID: 7740506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood levels of ditazole and inhibition of platelet aggregation in man.
    de Gaetano G; Dal Bo L; Villa S; Mussini E; Marcucci F
    Arzneimittelforschung; 1980; 30(3):496-7. PubMed ID: 6104495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors responsible for ADP-induced release reaction of human platelets.
    Mustard JF; Perry DW; Kinlough-Rathbone RL; Packham MA
    Am J Physiol; 1975 Jun; 228(6):1757-65. PubMed ID: 50744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of aspirin and indomethacin on the platelet contractile wave.
    Gerrard JM; White JG
    Am J Pathol; 1976 Mar; 82(3):513-26. PubMed ID: 1258974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
    Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
    Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease and cyclooxygenase inhibitors synergistically prevent activation of human platelets.
    Ruggiero M; Lapetina EG
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3456-9. PubMed ID: 3458190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.